| 0 |
DRUG INEFFECTIVE |
33 |
| 1 |
DEATH |
17 |
| 2 |
FALL |
14 |
| 3 |
PSYCHOTIC DISORDER |
14 |
| 4 |
HALLUCINATION |
12 |
| 5 |
OFF LABEL USE |
12 |
| 6 |
CONFUSIONAL STATE |
10 |
| 7 |
DRUG INTERACTION |
9 |
| 8 |
NEUTROPENIA |
9 |
| 9 |
THERAPEUTIC RESPONSE UNEXPECTED |
9 |
| 10 |
COGNITIVE DISORDER |
8 |
| 11 |
CONDITION AGGRAVATED |
8 |
| 12 |
SPUR CELL ANAEMIA |
8 |
| 13 |
BALANCE DISORDER |
7 |
| 14 |
ABNORMAL BEHAVIOUR |
6 |
| 15 |
AGGRESSION |
6 |
| 16 |
AGITATION |
6 |
| 17 |
ANXIETY |
6 |
| 18 |
DRUG INTOLERANCE |
6 |
| 19 |
LOW DENSITY LIPOPROTEIN DECREASED |
6 |
| 20 |
MENTAL STATUS CHANGES |
6 |
| 21 |
MOTOR DYSFUNCTION |
6 |
| 22 |
SOMNOLENCE |
6 |
| 23 |
DELUSION |
5 |
| 24 |
GAIT DISTURBANCE |
5 |
| 25 |
NEUROLEPTIC MALIGNANT SYNDROME |
5 |
| 26 |
PRODUCT USE IN UNAPPROVED INDICATION |
5 |
| 27 |
ASTHENIA |
4 |
| 28 |
BRADYCARDIA |
4 |
| 29 |
DEHYDRATION |
4 |
| 30 |
DEMENTIA |
4 |
| 31 |
DEVICE ISSUE |
4 |
| 32 |
DIZZINESS |
4 |
| 33 |
HALLUCINATION, VISUAL |
4 |
| 34 |
HYPOTENSION |
4 |
| 35 |
NAUSEA |
4 |
| 36 |
NEUROPSYCHIATRIC SYMPTOMS |
4 |
| 37 |
OEDEMA |
4 |
| 38 |
PARKINSON^S DISEASE |
4 |
| 39 |
PYREXIA |
4 |
| 40 |
SEDATION |
4 |
| 41 |
TREATMENT FAILURE |
4 |
| 42 |
URINARY TRACT INFECTION |
4 |
| 43 |
ANAEMIA MACROCYTIC |
3 |
| 44 |
DELIRIUM |
3 |
| 45 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
3 |
| 46 |
HAEMOLYSIS |
3 |
| 47 |
HIP FRACTURE |
3 |
| 48 |
LETHARGY |
3 |
| 49 |
ORTHOSTATIC HYPOTENSION |
3 |
| 50 |
PARANOIA |
3 |
| 51 |
PARKINSON^S DISEASE PSYCHOSIS |
3 |
| 52 |
PNEUMONIA ASPIRATION |
3 |
| 53 |
PURPURA |
3 |
| 54 |
SEPSIS |
3 |
| 55 |
BRADYPHRENIA |
2 |
| 56 |
CARDIAC ARREST |
2 |
| 57 |
CEREBROVASCULAR ACCIDENT |
2 |
| 58 |
CONSTIPATION |
2 |
| 59 |
COUGH |
2 |
| 60 |
DEEP VEIN THROMBOSIS |
2 |
| 61 |
DEVICE DISLOCATION |
2 |
| 62 |
DISEASE PROGRESSION |
2 |
| 63 |
DISORIENTATION |
2 |
| 64 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
| 65 |
DYSKINESIA |
2 |
| 66 |
DYSPHAGIA |
2 |
| 67 |
HALLUCINATION, AUDITORY |
2 |
| 68 |
HYPOPHAGIA |
2 |
| 69 |
INFECTION |
2 |
| 70 |
INSOMNIA |
2 |
| 71 |
LANGUAGE DISORDER |
2 |
| 72 |
LEUKOCYTOSIS |
2 |
| 73 |
MEMORY IMPAIRMENT |
2 |
| 74 |
NEUTROPHIL COUNT DECREASED |
2 |
| 75 |
NEUTROPHIL COUNT INCREASED |
2 |
| 76 |
NIGHTMARE |
2 |
| 77 |
OEDEMA PERIPHERAL |
2 |
| 78 |
PAIN |
2 |
| 79 |
PERIPHERAL SWELLING |
2 |
| 80 |
PLEUROTHOTONUS |
2 |
| 81 |
RESPIRATORY ARREST |
2 |
| 82 |
RESTLESSNESS |
2 |
| 83 |
TREATMENT NONCOMPLIANCE |
2 |
| 84 |
TREMOR |
2 |
| 85 |
UNDERDOSE |
2 |
| 86 |
UNRESPONSIVE TO STIMULI |
2 |
| 87 |
WEIGHT DECREASED |
2 |
| 88 |
ANGER |
1 |
| 89 |
ANOXIA |
1 |
| 90 |
ARRHYTHMIA |
1 |
| 91 |
ARTERIAL INJURY |
1 |
| 92 |
ASPIRATION |
1 |
| 93 |
ATRIAL FIBRILLATION |
1 |
| 94 |
BASOPHIL COUNT INCREASED |
1 |
| 95 |
BLINDNESS |
1 |
| 96 |
BLOOD CHOLESTEROL INCREASED |
1 |
| 97 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
| 98 |
BLOOD DISORDER |
1 |
| 99 |
BLOOD PRESSURE DECREASED |
1 |
| 100 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
| 101 |
BRONCHITIS |
1 |
| 102 |
C-REACTIVE PROTEIN INCREASED |
1 |
| 103 |
CARCINOID TUMOUR |
1 |
| 104 |
CEREBRAL ATROPHY |
1 |
| 105 |
CEREBRAL HAEMORRHAGE |
1 |
| 106 |
CHEST PAIN |
1 |
| 107 |
CHOKING |
1 |
| 108 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
| 109 |
CONTUSION |
1 |
| 110 |
COVID-19 |
1 |
| 111 |
DECREASED APPETITE |
1 |
| 112 |
DELUSIONAL PERCEPTION |
1 |
| 113 |
DEPRESSION |
1 |
| 114 |
DEVICE ALARM ISSUE |
1 |
| 115 |
DEVICE DIFFICULT TO USE |
1 |
| 116 |
DISTURBANCE IN ATTENTION |
1 |
| 117 |
DROOLING |
1 |
| 118 |
DRUG LEVEL INCREASED |
1 |
| 119 |
DRUG-DISEASE INTERACTION |
1 |
| 120 |
DYSARTHRIA |
1 |
| 121 |
DYSSTASIA |
1 |
| 122 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
| 123 |
EMBOLISM |
1 |
| 124 |
EMERGENCY CARE |
1 |
| 125 |
ERECTION INCREASED |
1 |
| 126 |
ERYTHEMA |
1 |
| 127 |
EXCESSIVE SKIN |
1 |
| 128 |
EXTRAPYRAMIDAL DISORDER |
1 |
| 129 |
FATIGUE |
1 |
| 130 |
FEEDING DISORDER |
1 |
| 131 |
FLUSHING |
1 |
| 132 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
| 133 |
HAEMATOCRIT INCREASED |
1 |
| 134 |
HAEMATURIA |
1 |
| 135 |
HAEMOGLOBIN INCREASED |
1 |
| 136 |
HALLUCINATION, TACTILE |
1 |
| 137 |
HOSPITALISATION |
1 |
| 138 |
HYPERTENSION |
1 |
| 139 |
HYPOKINESIA |
1 |
| 140 |
HYPOTHERMIA |
1 |
| 141 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
| 142 |
INCORRECT DOSE ADMINISTERED |
1 |
| 143 |
INFLUENZA |
1 |
| 144 |
INFUSION SITE CELLULITIS |
1 |
| 145 |
INFUSION SITE RASH |
1 |
| 146 |
INFUSION SITE REACTION |
1 |
| 147 |
INTENTIONAL OVERDOSE |
1 |
| 148 |
INTRAOCULAR LENS IMPLANT |
1 |
| 149 |
IRRITABILITY |
1 |
| 150 |
JOINT RANGE OF MOTION DECREASED |
1 |
| 151 |
LATENT AUTOIMMUNE DIABETES IN ADULTS |
1 |
| 152 |
LEUKOPENIA |
1 |
| 153 |
LIMB MASS |
1 |
| 154 |
LIVING IN RESIDENTIAL INSTITUTION |
1 |
| 155 |
LOSS OF CONSCIOUSNESS |
1 |
| 156 |
LOW DENSITY LIPOPROTEIN INCREASED |
1 |
| 157 |
LYMPHOCYTE COUNT DECREASED |
1 |
| 158 |
LYMPHOCYTE COUNT INCREASED |
1 |
| 159 |
LYMPHOEDEMA |
1 |
| 160 |
MALAISE |
1 |
| 161 |
MANIA |
1 |
| 162 |
MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED |
1 |
| 163 |
MEAN CELL VOLUME INCREASED |
1 |
| 164 |
MEDICAL DEVICE SITE INFECTION |
1 |
| 165 |
MENTAL DISORDER |
1 |
| 166 |
MENTAL IMPAIRMENT |
1 |
| 167 |
METABOLIC DISORDER |
1 |
| 168 |
MOBILITY DECREASED |
1 |
| 169 |
MONOCYTE COUNT DECREASED |
1 |
| 170 |
MONOCYTE COUNT INCREASED |
1 |
| 171 |
MUSCLE RIGIDITY |
1 |
| 172 |
MUSCULOSKELETAL STIFFNESS |
1 |
| 173 |
NEOPLASM |
1 |
| 174 |
NO ADVERSE EVENT |
1 |
| 175 |
NONSPECIFIC REACTION |
1 |
| 176 |
OCULOGYRIC CRISIS |
1 |
| 177 |
PANIC ATTACK |
1 |
| 178 |
PELVIC FRACTURE |
1 |
| 179 |
PERSECUTORY DELUSION |
1 |
| 180 |
PLATELET COUNT DECREASED |
1 |
| 181 |
PNEUMONIA BACTERIAL |
1 |
| 182 |
POOR QUALITY SLEEP |
1 |
| 183 |
PRESCRIBED UNDERDOSE |
1 |
| 184 |
PRODUCT USE ISSUE |
1 |
| 185 |
PROSTATIC OPERATION |
1 |
| 186 |
PROSTATITIS |
1 |
| 187 |
PULMONARY EMBOLISM |
1 |
| 188 |
RASH |
1 |
| 189 |
RASH PRURITIC |
1 |
| 190 |
RED BLOOD CELL COUNT INCREASED |
1 |
| 191 |
REHABILITATION THERAPY |
1 |
| 192 |
RESTING TREMOR |
1 |
| 193 |
RIB FRACTURE |
1 |
| 194 |
SCHIZOPHRENIA |
1 |
| 195 |
SEDATION COMPLICATION |
1 |
| 196 |
SEIZURE |
1 |
| 197 |
SENSORY DISTURBANCE |
1 |
| 198 |
SLEEP DISORDER |
1 |
| 199 |
SOLILOQUY |
1 |
| 200 |
SPEECH DISORDER |
1 |
| 201 |
SPLENIC RUPTURE |
1 |
| 202 |
STOMA COMPLICATION |
1 |
| 203 |
SUICIDAL IDEATION |
1 |
| 204 |
SUICIDE ATTEMPT |
1 |
| 205 |
SUPINE HYPERTENSION |
1 |
| 206 |
SYNCOPE |
1 |
| 207 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
| 208 |
THERAPEUTIC RESPONSE DECREASED |
1 |
| 209 |
THERAPY NON-RESPONDER |
1 |
| 210 |
THERAPY PARTIAL RESPONDER |
1 |
| 211 |
TRAUMATIC LIVER INJURY |
1 |
| 212 |
UNEVALUABLE EVENT |
1 |
| 213 |
VISUAL IMPAIRMENT |
1 |
| 214 |
WEIGHT INCREASED |
1 |
| 215 |
WHITE BLOOD CELL COUNT INCREASED |
1 |